Advancing a game-changing technology like MR-guided focused ultrasound from research bench to clinical reality requires the contribution of many stakeholders. One such group – first-to-be-treated patients – often goes unsung.
The January issue of the FUS Foundation newsletter provides an engaging profile of Doris McArdle, an indomitable 89-year-old who and recipient of the first MR-guided focused ultrasound treatment for a benign pancreatic tumor. Performed on a compassionate care basis at St. Mary’s Hospital in London, England, the treatment ablated about a fourth of Mrs. McArdle’s sizable tumor and has relieved about 75 percent of her persistent pain.
Click here to read the complete details of Mrs. McArdles's treatment and recovery.